Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders

Bibliographic Details
Published in:	Neural Regeneration Research
Main Authors:	Austin Lui, Omar Alzayat, Timothy Do, David Perekopskiy, Meghan Gann, Taiseer Saad Elgokhy, Jie Gao, DaZhi Liu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=4;spage=805;epage=806;aulast=Lui

Similar Items

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
by: Austin Lui, et al.
Published: (2022-12-01)

Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
by: Austin Lui, et al.
Published: (2024-03-01)

Anti-inflammatory effect of curcumin on neurological disorders: a narrative review
by: Baoyin Zhou, et al.
Published: (2025-10-01)

Bioactive compounds in Chinese herbal medicine: anti-inflammatory mechanisms targeting neurological disorders
by: Liangxue Zhang, et al.
Published: (2025-10-01)

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)
by: Hassan Aliashrafzadeh, et al.
Published: (2025-07-01)

Antioxidant and Anti-Inflammatory Effects of <i>Citrus</i> Flavonoid Hesperetin: Special Focus on Neurological Disorders
by: Amjad Khan, et al.
Published: (2020-07-01)

Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders
by: Takeshi Kondo, et al.
Published: (2024-06-01)

Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
by: Joanne M. Jeter, et al.
Published: (2011-01-01)

Retinal correlates of neurological disorders
by: Timothy E. Yap, et al.
Published: (2019-11-01)

Neurological and Neurobehavioral Disorders Associated with Toxoplasma gondii Infection in Humans
by: Maxwell A. Virus, et al.
Published: (2021-01-01)

Editorial: Chemotherapy and other pharmacotherapies for canine neurological disorders
by: R. Timothy Bentley, et al.
Published: (2023-10-01)

O34: Utility of targeted RNA analysis in neurological disorders
by: Shoji Ichikawa, et al.
Published: (2024-01-01)

Nonsteroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
by: Ingvar Bjarnason, et al.
Published: (1993-01-01)

Editorial: Immune therapies in neurological disorders
by: Jie Pan
Published: (2025-05-01)

CSF oligoclonal bands in neurological diseases besides CNS inflammatory demyelinating disorders
by: Feng Gao, et al.
Published: (2025-02-01)

Contribution of Pro-Inflammatory Molecules Induced by Respiratory Virus Infections to Neurological Disorders
by: Karen Bohmwald, et al.
Published: (2021-04-01)

The Epidemiology of Nonsteroidal Anti-Inflammatory Drugs
by: Jerry Tenenbaum
Published: (1999-01-01)

Anti-inflammatory drugs in COVID-19
by: Mohamed Elnady
Published: (2021-01-01)

Nonsteroidal anti‐inflammatory drugs and pharyngitis
by: Stuart B Mazzone, et al.
Published: (2022-12-01)

Nonsteroidal Anti-Inflammatory Drugs and the Kidney
by: Walter H. Hörl
Published: (2010-07-01)

A drug screening platform for protein expression levels in neurological disorders
by: Farida Emran, et al.
Published: (2025-03-01)

Potential therapeutics against neurological disorders: Natural products-based drugs
by: Abdur Rauf, et al.
Published: (2022-08-01)

Concussion research at the National Institutes of Health: an update from the National Institute of Neurological Disorders and Stroke
by: Meghan Mott, et al.
Published: (2015-10-01)

Concussion research at the National Institutes of Health: an update from the National Institute of Neurological Disorders and Stroke
by: Meghan Mott, et al.
Published: (2016-03-01)

Circulating Metabolites as Potential Biomarkers for Neurological Disorders—Metabolites in Neurological Disorders
by: Amanda Donatti, et al.
Published: (2020-09-01)

Anti-metastatic Action of Non-steroidal Anti-inflammatory Drugs
by: Wen-Chun Hung
Published: (2008-08-01)

From inflammatory signaling to neuronal damage: Exploring NLR inflammasomes in ageing neurological disorders
by: Jingwen Zhang, et al.
Published: (2024-06-01)

Recent Advances in the Anti-Inflammatory Activity of Plant-Derived Alkaloid Rhynchophylline in Neurological and Cardiovascular Diseases
by: Rajeswari Gopal Geetha, et al.
Published: (2021-07-01)

The neurologic pain signature responds to nonsteroidal anti-inflammatory treatment vs placebo in knee osteoarthritis
by: Marina López-Solà, et al.
Published: (2022-04-01)

Benefits of liposomal nonsteroid-anti-inflammatory drugs
by: Marković Srđan Z., et al.
Published: (2022-01-01)

Effects of anti-inflammatory drugs on dental displacement
by: Amina Mezari, et al.
Published: (2022-01-01)

BIOPHARMACEUTICAL PROPERTIES OF THE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
by: Y. I. Kulinich
Published: (2012-03-01)

Effects of nonsteroidal anti-inflammatory drugs on hearing
by: Oğuz Güçlü, et al.
Published: (2012-03-01)

Nonsteroidal anti-inflammatory drugs in therapy for osteoarthrosis
by: V. V. Badokin
Published: (2009-03-01)

Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease
by: Scott D. Schoenberger, et al.
Published: (2013-01-01)

Anti-inflammatory drugs slash Alzheimer risk
by: Christie Aschwanden

Enteropathy induced by nonsteroid anti-inflammatory drugs
by: A E Karateev, et al.
Published: (2004-02-01)

Dysphagia in neurological disorders
by: Sofya A. Zaytsevskaya, et al.
Published: (2024-07-01)

Navigating neurological disorders
by: Rapuru Rushendran, et al.
Published: (2024-04-01)

Genomics in Neurological Disorders
by: Guangchun Han, et al.
Published: (2014-08-01)